SEC Form 4 · accession 0001437749-19-003088
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Borys
Officer — CMO
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $2.18 | Feb 19, 2019 | A | 20,000 | A | Feb 19, 2020 | Feb 19, 2029 | Celsion Corporation Common Stock | 20,000 | 325,047 | D |
Explanation of responses
- F1Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F2The options vest as follows: 1/3 on the one year anniversary of the date of grant; 1/3 on the second year anniversary of the date of grant; and 1/3 on the third year anniversary of the date of grant.